You are here

REMOTE EXPERT SCREENING FOR DIABETIC RETINOPATHY

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R42EY012457-02A1
Agency Tracking Number: EY012457
Amount: $0.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2002
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
EYETEL CORPORATION 15078 STILLFIELD PL
CENTREVILLE, VA 20120
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 TORRE MEEDER
 (703) 803-8584
 TORRE@EYETEL-IMAGINING.COM
Business Contact
 KEVIN QUINN
Phone: (703) 803-8584
Email: KEVIN@EYETEL-IMAGINING.COM
Research Institution
 JOHNS HOPKINS HOSPITAL, WILMER EYE INSTITUTE
 
WILMER EYE INSTITUTE
BALTIMORE, MD 20287
United States

 Nonprofit College or University
Abstract

Half of diabetic patients do not visit an ophthalmologist as recommended, resulting in frequent and unnecessary vision loss. The NEI has set as an Healthy People 2010 objective to increase the screening rate for diabetic retinopathy. EyeTel-lmaging and the Wilmer Eye Institute are developing technology to screen diabetic patients during their visits to their primary care physician (PCP). The DigiScope, a low cost, quasi-automatic computerized fundus camera acquires digital stereoscopic fundus images and assesses visual acuity. The data are automatically transferred, via the Internet, to a reading center where expert readers, supervised by retinal specialists, identify patients with retinopathy and refer them to an ophthalmologist. The DigiScope will be provided to PCPs without capital investment on their part and a service fee will be collected from health care providers. The goals of Phase I were exceeded with the successful development of the DigiScope and the results of an independent study. In comparison with the 'gold standard', the DigiScope had a sensitivity of 98.5 percent and a specificity of 92 percent. The goals of phase II are to meet all the specifications for implementation in PCPs offices, develop the reading center and assess the impact on screening rate in different health care environments.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government